Loading...
XSHE000525
Market cap1.10bUSD
Jan 14, Last price  
6.22CNY
1D
1.47%
1Q
-33.90%
Jan 2017
-63.88%
Name

Nanjing Red Sun Co Ltd

Chart & Performance

D1W1MN
XSHE:000525 chart
P/E
—
P/S
2.50
EPS
—
Div Yield, %
0.64%
Shrs. gr., 5y
—
Rev. gr., 5y
-11.36%
Revenues
3.23b
-49.81%
1,708,055,6892,198,582,4752,827,389,5543,285,075,3903,498,651,0543,548,706,4603,808,848,7905,789,356,0237,175,366,0087,269,322,8786,876,222,9694,557,715,9433,537,512,4374,974,184,6655,908,271,4164,614,454,4694,021,995,2024,683,382,0316,439,912,6583,232,236,356
Net income
-389m
L
48,227,43933,911,99132,676,65018,880,03210,966,8223,619,027068,693,533290,317,665371,992,604427,082,977181,947,835126,413,057697,555,721636,676,441000732,389,881-389,116,496
CFO
533m
-53.35%
140,804,402037,390,44686,074,8100219,558,4830109,881,160291,269,9941,024,896,502779,879,197245,746,855266,184,114514,335,777377,641,0811,464,507,715231,238,358348,634,7811,142,420,374532,909,196
Dividend
Jul 19, 20190.15 CNY/sh
Earnings
Jun 27, 2025

Profile

Nanjing Red Sun Co.,Ltd. engages in the research, manufacture, and sale of pesticides and other chemicals in China. The company offers herbicides, insecticides, fungicides, animal nutrition, and three-drug intermediates, as well as fine chemicals. It also provides technical consultation and product customization services. The company was founded in 1989 and is based in Nanjing, China.
URL
http://www.chinaredsun.com/
IPO date
Oct 28, 1993
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
3,232,236
-49.81%
6,439,913
37.51%
Cost of revenue
3,631,492
4,520,942
Unusual Expense (Income)
NOPBT
(399,256)
1,918,970
NOPBT Margin
29.80%
Operating Taxes
(149,785)
82,388
Tax Rate
4.29%
NOPAT
(249,471)
1,836,582
Net income
(389,116)
-153.13%
732,390
 
Dividends
(51,320)
Dividend yield
1.04%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
3,365,854
4,235,770
Long-term debt
241,044
328,332
Deferred revenue
51,955
65,228
Other long-term liabilities
1,359,018
1,572,279
Net debt
3,063,436
3,946,155
Cash flow
Cash from operating activities
532,909
1,142,420
CAPEX
(49,641)
Cash from investing activities
(49,641)
Cash from financing activities
(574,554)
FCF
1,084,081
1,965,054
Balance
Cash
339,315
594,860
Long term investments
204,147
23,087
Excess cash
381,850
295,951
Stockholders' equity
699,474
1,300,069
Invested Capital
5,675,859
7,201,536
ROIC
25.42%
ROCE
25.44%
EV
Common stock shares outstanding
580,771
580,773
Price
8.53
-26.47%
11.60
31.82%
Market cap
4,953,976
-26.47%
6,736,965
31.82%
EV
8,136,113
10,810,130
EBITDA
31,185
2,365,503
EV/EBITDA
260.90
4.57
Interest
345,681
351,161
Interest/NOPBT
18.30%